RSM logo
JRSM

Home Current issue Browse archive Alerts About the journal Feedback
 
J R Soc Med 2008;101:290-298
doi:10.1258/jrsm.2008.070372
© 2008 Royal Society of Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Send a Quick Comment
Right arrow Quick Comments: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Quick Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JRSM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Key, S.
Right arrow Articles by Drake, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Review

Genetically modified plants and human health

Suzie Key Julian K-C Ma   Pascal MW Drake

Molecular Immunology Unit, Centre for Infection, Department of Cellular and Molecular Medicine, St George's University of London Cranmer Terrace, London SW17 0RE, UK

Correspondence to: Pascal MW Drake pdrake{at}sgul.ac.uk

SUMMARY

Genetically modified (or GM) plants have attracted a large amount of media attention in recent years and continue to do so. Despite this, the general public remains largely unaware of what a GM plant actually is or what advantages and disadvantages the technology has to offer, particularly with regard to the range of applications for which they can be used. From the first generation of GM crops, two main areas of concern have emerged, namely risk to the environment and risk to human health. As GM plants are gradually being introduced into the European Union there is likely to be increasing public concern regarding potential health issues. Although it is now commonplace for the press to adopt ‘health campaigns’, the information they publish is often unreliable and unrepresentative of the available scientific evidence. We consider it important that the medical profession should be aware of the state of the art, and, as they are often the first port of call for a concerned patient, be in a position to provide an informed opinion.

This review will examine how GM plants may impact on human health both directly – through applications targeted at nutrition and enhancement of recombinant medicine production – but also indirectly, through potential effects on the environment. Finally, it will examine the most important opposition currently facing the worldwide adoption of this technology: public opinion.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related articles in JRSM:

Errors in text
David Schubert
JRSM 2008 101: 435. [Full Text]  



This article has been cited by other articles:


Home page
Crop Sci.Home page
K. B. R. S. Visarada, K. Meena, C. Aruna, S. Srujana, N. Saikishore, and N. Seetharama
Transgenic Breeding: Perspectives and Prospects
Crop Sci., August 7, 2009; 49(5): 1555 - 1563.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
D. Schubert
Errors in text
J R Soc Med, September 1, 2008; 101(9): 435 - 435.
[Full Text] [PDF]

Quick Comments:

Read all Quick Comments

Errors in Text
David Schubert
JRSM Online, 1 Aug 2008 [Full text]
Serious Concerns
Ian E Panton
JRSM Online, 3 Aug 2008 [Full text]


Get Through Series